Kristin Waldenlind | Karolinska Institutet

Artiklar

Article: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):313-321
Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis
Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
Article: RMD OPEN. 2020;6(2):e001282
Does autoimmune thyroid disease affects rheumatoid arthritis disease activity or response to methotrexate?
Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
Article: JAMA NETWORK OPEN. 2018;1(6):e183567
Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis
Waldenlind K; Saevarsdottir S; Bengtsson C; Askling J
Article: BMC MUSCULOSKELETAL DISORDERS. 2014;15:432
Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County
Waldenlind K; Eriksson JK; Grewin B; Askling J

Alla övriga publikationer

Doctoral thesis: 2022
The impact of autoimmune thyroid disease (AITD) on rheumatoid arthritis (RA) and the impact of RA on AITD
Waldenlind K